PharmD Professor

US Pharm. 2025;50(9):26-30. ABSTRACT: Osteoporosis is a skeletal disorder that is characterized by reduced bone mass, leading to increased risk of fractures and spinal compression. It predominantly affects postmenopausal women, but it can occur in men and individuals with other risk factors. Prevention and treatment of osteoporosis involve a multifaceted approach, including lifestyle and nutritional modifications, physical activity, fall-prevention strategies, and pharmacotherapy.

US Pharm. 2025;50(2):HS2-HS8. ABSTRACT: Myocardial infarction (MI) continues to be a leading cause of death in the United States. Improvements in the diagnosis and treatment of acute MI have reduced in-hospital mortality from 30% in the 1970s to about 5% currently. The traditional functions of hospital pharmacists in MI care involve patient education and counseling on risk-factor modification and drug therapy.

US Pharm. 2024;49(4):HS1-HS5. ABSTRACT: Over the past few years, the FDA has approved several new antibiotics to combat resistant bacteria. These new drugs are used primarily in the hospital setting, although some are also employed in outpatient clinics or administered by home healthcare agencies. Many of these antibiotics may be restricted to use by infectious-disease physicians or antimicrobial-stewardship teams, on which pharmacists can play an extremely important role.